GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.42X leverage
Performance
- Low
- ₹2,032
- High
- ₹2,081
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,032
- Previous Close₹2,039
- Volume223,376
Investment Returns
- Over 1 Month + 5.41%
- Over 3 Month + 4.77%
- Over 6 Month + 13.34%
- Over 1 Year + 26.8%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 58
- PEG Ratio
- 0.3
- Market Cap Cr
- 58,545
- P/B Ratio
- 6.1
- Average True Range
- 41.38
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 30.41
- RSI
- 65.51
- MFI
- 76.29
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,074.60
+
35.4
(1.74%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹2,008.17
- 50 Day
- ₹1,966.45
- 100 Day
- ₹1,928.57
- 200 Day
- ₹1,829.67
Resistance and Support
2062.3
- R3 2,142.40
- R2 2,111.60
- R1 2,093.10
- S1 2,043.80
- S2 2,013.00
- S3 1,994.50
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,074 As on 06 January, 2026 | 21:37
The Market Cap of Glenmark Pharmaceuticals is ₹58545.4 Cr As on 06 January, 2026 | 21:37
The P/E ratio of Glenmark Pharmaceuticals is 58 As on 06 January, 2026 | 21:37
The PB ratio of Glenmark Pharmaceuticals is 6.1 As on 06 January, 2026 | 21:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.